Scroll
revolutionizing access to health information
The Fluxergy Analyzer platform combines the capabilities of many machines into one multimodal system, delivering more affordable laboratory-quality test results and actionable metrics in 1 hour or less.
Request More Information
Addressing industry needs through collaboration
Our platform enable us to provide a diverse portfolio of assays designed to meet the needs of communities and markets around the world.
Request More Information
Designed and Manufactured in Irvine, California
We proudly develop our hardware, software, biologics, and consumables leveraging full design and production control.
Request More Information
Previous
Next

APPLICATIONS ACROSS INDUSTRIES

human diagnostics

Human Diagnostics

life sciences

Life Sciences

oem

OEM

Accurate and Rapid PCR Testing at Pharmacies and Clinics

We deploy platforms in regions that accept CE-IVD to address community-based needs for COVID-19 and respiratory panel testing.

julia horse

Stall-Side Pathogen Testing to Protect the Equine Industry

Improving in-clinic diagnostics with the release of a Salmonella PCR assay and development of an EHV-1, S. equi equi, and respiratory panel assay.

On-Site Laboratory Testing for Food Production Facilities

Helping farmers, food manufacturers, and retailers enable faster in-process testing of pathogens and allergens.

fluxergy employees

Co-Development of Assays with Industry Leaders

Collaboration is part of Fluxergy’s value system: several companies are porting their assays onto the Fluxergy analyzer platform and consumable system to reach the point-of-care.

fluxergy works

Personalized Medicine for Home and Chronic Care

Fluxergy is working on at-home hardware, software, and consumable technologies for people who can benefit from daily and weekly home testing.

wyss fluxergy

Tackling Unmet Needs with a Novel Diagnostics Accelerator

Fluxergy has joined the Wyss Institute at Harvard to work with diagnostic stalwarts and technologies to address early diagnoses for several diseases.

Accurate and Rapid PCR Testing at Pharmacies and Clinics
We deploy platforms in regions that accept CE-IVD to address community-based needs for COVID-19 and respiratory panel testing.
Stall-Side Pathogen Testing to Protect the Equine Industry
Improving in-clinic diagnostics with the release of a salmonella PCR assay and development of an EHV-1, S. equi, and respiratory panel assay.
On-Site Laboratory Testing for Food Production Facilities
Helping farmers, food manufacturers, and retailers enable faster in-process testing of pathogens and allergens.
Co-Development of Assays with Industry Leaders
Collaboration is part of Fluxergy’s value system: several companies are porting their assays onto the Fluxergy analyzer platform and consumable system to reach the point-of-care.
Personalized Medicine for Home and Chronic Care
Fluxergy is working on at-home hardware, software, and consumable technologies for people who can benefit from daily and weekly home testing.
Tackling Unmet Needs with a Novel Diagnostics Accelerator
Fluxergy has joined the Wyss Institute at Harvard to work with diagnostic stalwarts and technologies to address early diagnoses for several diseases.
Previous
Next

FLUXERGY'S 3 CORE TECHNOLOGIES

fluxergy test cards

Fluxergy Cards

Mulitplex & mutlimodal single-use test cards for rapid sample-to-answer testing.

Fluxergy Analyzer

A multimodal testing system designed to quickly detect molecules, chemicals, cells, and more.

fluxergy works software

Fluxergy Works

A cloud or local user interface is capable of analyzing and disseminating data to users.

Trusted & Certified

These certifications demonstrate Fluxergy's commitment to compliance and effectiveness of our products and quality management system.

cgmp
iso 13485:2016
mdsap
ce ivd

Collaborate with Fluxergy

Schedule a call

What Experts Say About Fluxergy

“I love the Fluxergy Platform – I really do. You take your swab, mix it with the Fluxergy Reaction Mix, you load that in the test card, you stick it in the analyzer, and you wait an hour and the test is done. It’s really simple.”
Caroline Ignacio​
Caroline Ignacio​Laboratory Manger UCSD Department of Medicine, CFAR Translational Virology Core​
“Two things about the Fluxergy system stand out, especially in the case of a viral pandemic: its accuracy using RT-PCR technology and its ability to deliver results in 1 hour at the point-of-care.”
Dr. David Smith, MD, MAS, FACP, FIDSA​
Dr. David Smith, MD, MAS, FACP, FIDSA​Professor of Medicine, Head of the UCSD Division of Infectious Diseases And Global Public Health Member of Fluxergy’s Advisory Board
"Fluxergy's advance technology can be used on equine patients in order to allow for proper treatment and timely biosecurity. The novel platform can turn a 1 to 3 day turnaround time into an hour processing time."
Dr. Nicola Pusterla, PhD, Dip ACVIM, AVDC
Dr. Nicola Pusterla, PhD, Dip ACVIM, AVDCLeading Equine Infectious Disease Expert​
"Fluxergy is at the forefront of diagnostic capabilities with PCR. The PCR run-time is quick and easy. As we improve our care through newer technologies and diagnostics, such as Fluxergy, we better educate our clients on what is causing the problem."
Dr. Paul Wan, DVM, Dip ACVS, Cert. VBM​
Dr. Paul Wan, DVM, Dip ACVS, Cert. VBM​Veterinarian Practitioner Owner at SoCal Equine Hospital
"The Fluxergy platform’s speed, with results in one hour, and accuracy by using qPCR molecular technology are potentially strong benefits for clincal settings, especially when a quick result is needed. I also see the future value of the multimodal technology where you could potentially have different types of tests on a single point-of-care platform."
Lee B. Springer, PhD
Lee B. Springer, PhDLaboratory Director at C3 Clincal Consulting Services
“I learned of Fluxergy’s technology when I was at Boehringer Ingelheim, and I was impressed about the opportunity for this pointof- care testing platform. I am happy to be involved on Fluxergy’s advisory board where I can bring my 20+ years of animal health and R&D experience. One of the big advantages of Fluxergy’s technology is that it is very easy to use. When veterinarians see horses with high fevers, its important that they can understand quickly what is going on.”
Dr. Randolph Seidler, VMD, MBA
Dr. Randolph Seidler, VMD, MBAFormer global head of R&D and business development for Boehringer Ingelheim Animal Health and Member of Fluxergy’s Advisory Board
“Having the capability to detect Streptococcus equi equi stall-side is an exciting step forward for equine diagnostic testing. The point-of-care PCR platform provides acceptable PCR performance when compared to traditional lab methods and provides an opportunity to save shipping costs and time for veterinarians.”
Dr. Andrew Willis, DVM, DACVIM
Dr. Andrew Willis, DVM, DACVIMBrazos Valley Equine Hospitals
"The ability to offer PCR out of our laboratory opens several new possibilities for our practice, such as a 1 hour test result time for infectious pathogens."
Laura H. Javiscas, VMD, Dip ACVIM
Laura H. Javiscas, VMD, Dip ACVIMRhinebeck Equine, LLP
"Fluxergy's technology has a great potential to start a new era in the diagnostic field. Fluxergy's portable, user-friendly, and cost-effective PCR technology provides highly accurate results in less than an hour, which is needed to control the spread of infectious diseases."
Dr. Lucjan Witkowski, DVM, PhD
Dr. Lucjan Witkowski, DVM, PhDWarsaw University of Life Sciences
"The most exciting thing is that I can turn a stall around in 18 hours and feel very comfortable that my stall is clean and safe to put another horse in. Being able to get that answer quickly is beautiful."
Dr. Ben Buchanan, DVM, DACVIM, DACVECC
Dr. Ben Buchanan, DVM, DACVIM, DACVECCOwner of Brazos Valley Equine Hospitals
"Fluxergy's platform has the capability to change how we handle strangles cases. Being able use PCR to test for S. equi with an hour with a simple workflow will allow me to offer a result immediately to my client and justify where the patient goes or doesn't go. If they can add additional pathogens to create a respriatory panel, then even better. Our practice has been watching Fluxergy's technology grow from an early stage startup and are happy to support innovation that will help our industry."
Charlie Buchanan, DVM
Charlie Buchanan, DVMOwner of Signature Equine Hospital
Previous
Next
“I love the Fluxergy Platform – I really do. You take your swab, mix it with the Fluxergy Reaction Mix, you load that in the test card, you stick it in the analyzer, and you wait an hour and the test is done. It’s really simple.”
Caroline Ignacio​Laboratory Manger UCSD Department of Medicine, CFAR Translational Virology Core​
Caroline Ignacio​
“Two things about the Fluxergy system stand out, especially in the case of a viral pandemic: its accuracy using RT-PCR technology and its ability to deliver results in 1 hour at the point-of-care.”
Dr. David Smith, MD, MAS, FACP, FIDSA​Professor of Medicine, Head of the UCSD Division of Infectious Diseases And Global Public Health Member of Fluxergy’s Advisory Board
Dr. David Smith, MD, MAS, FACP, FIDSA​
"Fluxergy's advance technology can be used on equine patients in order to allow for proper treatment and timely biosecurity. The novel platform can turn a 1 to 3 day turnaround time into an hour processing time."
Dr. Nicola Pusterla, PhD, Dip ACVIM, AVDCLeading Equine Infectious Disease Expert​
Dr. Nicola Pusterla, PhD, Dip ACVIM, AVDC
"Fluxergy is at the forefront of diagnostic capabilities with PCR. The PCR run-time is quick and easy. As we improve our care through newer technologies and diagnostics, such as Fluxergy, we better educate our clients on what is causing the problem."
Dr. Paul Wan, DVM, Dip ACVS, Cert. VBM​Veterinarian Practitioner Owner at SoCal Equine Hospital
Dr. Paul Wan, DVM, Dip ACVS, Cert. VBM​
"The Fluxergy platform’s speed, with results in one hour, and accuracy by using qPCR molecular technology are potentially strong benefits for clincal settings, especially when a quick result is needed. I also see the future value of the multimodal technology where you could potentially have different types of tests on a single point-of-care platform."
Lee B. Springer, PhDLaboratory Director at C3 Clincal Consulting Services
Lee B. Springer, PhD
“I learned of Fluxergy’s technology when I was at Boehringer Ingelheim, and I was impressed about the opportunity for this pointof- care testing platform. I am happy to be involved on Fluxergy’s advisory board where I can bring my 20+ years of animal health and R&D experience. One of the big advantages of Fluxergy’s technology is that it is very easy to use. When veterinarians see horses with high fevers, its important that they can understand quickly what is going on.”
Dr. Randolph Seidler, VMD, MBAFormer global head of R&D and business development for Boehringer Ingelheim Animal Health and Member of Fluxergy’s Advisory Board
Dr. Randolph Seidler, VMD, MBA
“Having the capability to detect S. equi stall-side is an exciting step forward for equine diagnostic testing. The point-of-care PCR platform provides acceptable PCR performance when compared to traditional lab methods and provides an opportunity to save shipping costs and time for veterinarians.”
Dr. Andrew Willis, DVM, DACVIMBrazos Valley Equine Hospitals
Dr. Andrew Willis, DVM, DACVIM
"The ability to offer PCR out of our laboratory opens several new possibilities for our practice, such as a 1 hour test result time for infectious pathogens."
Laura H. Javiscas, VMD, Dip ACVIMRhinebeck Equine, LLP
"Fluxergy's technology has a great potential to start a new era in the diagnostic field. Fluxergy's portable, user-friendly, and cost-effective PCR technology provides highly accurate results in less than an hour, which is needed to control the spread of infectious diseases."
Dr. Lucjan Witkowski, DVM, PhDWarsaw University of Life Sciences
Dr. Lucjan Witkowski, DVM, PhD
"The most exciting thing is that I can turn a stall around in 18 hours and feel very comfortable that my stall is clean and safe to put another horse in. Being able to get that answer quickly is beautiful."
Dr. Ben Buchanan, DVM, DACVIM, DACVECCOwner of Brazos Valley Equine Hospitals
Dr. Ben Buchanan, DVM, DACVIM, DACVECC
"Fluxergy's platform has the capability to change how we handle strangles cases. Being able use PCR to test for S. equi with an hour with a simple workflow will allow me to offer a result immediately to my client and justify where the patient goes or doesn't go. If they can add additional pathogens to create a respriatory panel, then even better. Our practice has been watching Fluxergy's technology grow from an early stage startup and are happy to support innovation that will help our industry."
Charlie Buchanan, DVMOwner of Signature Equine Hospital
Charlie Buchanan, DVM
Previous
Next

Who We Work With

cfar
socal equine
22-05-10-website-logos-brazos
22-05-10-website-logos-rhinebeck
22-05-10-website-logos-aste
idaho equine
signature equine
al nawras
22-05-10-website-logos-md
22-05-10-website-logos-halton
amwell data services
uc davis veterinary hospital equine
Previous
Next

Find Us Here

food research institute
aaep
22-05-10-website-logos-medica
22-05-10-website-logos-eceim
analytica
22-05-10-website-logos-beva
22-05-10-website-logos-iafp
tri con
bio con
vet expo
22-05-10-website-logos-aacc
Previous
Next

Featured In

forbes
reuters
slovis
yahoo finance
orange county business journal
genome web
fox news
lab manager
360 dx
abc 7
Previous
Next

*Only Fluxergy Test Kit COVID-19 has been approved for CE-IVD and is available for any markets that accept CE marking as the valid regulatory approval. All other products or any other markets are For Research Use Only (RUO) and are not for use in diagnostic procedures.

*This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Fluxergy takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
*Although forward-looking statements contained in this website regarding Fluxergy’s objectives, plans, goals, strategies, future growth, business prospects and opportunities are based upon what Fluxergy management believes are reasonable assumptions, estimates, and other judgments, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.